Latest Prescription Drugs news
More Clinical Benefits of Molnupiravir ID’d in COVID-19
posted June 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
ADA: Once-Weekly Dulaglutide Ups Glycemic Control in Youth With T2D
posted June 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
ADA: Once-Weekly Tirzepatide Yields Lasting Weight Loss in Obesity
posted June 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
AE Risk Examined for Abiraterone, Enzalutamide in Prostate Cancer
posted June 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
